Heimdall Bio
PrivateLast Round
Seed
May 27, 2024
Company Overview
Heimdall Bio operates in AI, Data & Cloud Infrastructure and is based in Connecticut. Its latest recorded funding round was a Seed round in May 2024.
Heimdall Bio is a biotechnology company that develops AI-driven evaluation environments and metagenomics intelligence platforms for biodefense, biomolecular design, and synthetic biology research.
Sector
AI, Data & Cloud Infrastructure
Verticals
Biotechnology, AI Training Infrastructure, Drug Discovery, Synthetic Data, Defense Tech
Business Model
B2B
Customer Profile
Data as a Service, Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Heimdall Bio Comparables
Compare Heimdall Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Valthos | 63% | |
| OpenProtein.AI | 61% | |
| Edison Scientific | 61% |
For institutional investors. Book with your work email.
Heimdall Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Heimdall Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Audere Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2024
Audere Capital led the Seed round.
For institutional investors. Book with your work email.
Heimdall Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Heimdall Bio's valuation, stock price, and market status.
Is Heimdall Bio a public or private company?
Heimdall Bio is a private company.
What is the current stock price of Heimdall Bio?
Heimdall Bio is a private company, so its shares have no public market price. Caplight tracks Heimdall Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Heimdall Bio worth (valuation)?
Valuation information for Heimdall Bio is not publicly available.
Can I buy Heimdall Bio stock?
Heimdall Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Heimdall Bio's last funding round?
Heimdall Bio's most recent funding round was Seed on May 27, 2024.
Who are the main investors in Heimdall Bio?
Key investors in Heimdall Bio include Audere Capital.
Will Heimdall Bio IPO soon?
No public IPO plans have been announced for Heimdall Bio.
How can I track Heimdall Bio secondary market activity?
Caplight tracks bids, offers, and trades in Heimdall Bio's shares on secondary markets.